Clinical Trial Update: Contrast Enhanced Mammography in the Evaluation of Cancer of Unknown Primary Syndrome

View source ↗

Summary

This clinical trial investigates the use of contrast-enhanced mammography to evaluate cancer of unknown primary syndrome, with enrollment by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer of Unknown Primary

Snippet

Sponsor: Graziella di Grezia | Conditions: Breast Cancer Diagnosis, Breast Cancer Prevention | Status: ENROLLING_BY_INVITATION